SkinBioTherapeutics (SBTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Jul 2024 07:00 AM
RNS
Full year trading update
23 Jul 2024 07:00 AM
RNS
Closure of Convertible Bond Facility
22 Jul 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
15 Jul 2024 07:00 AM
RNS
Notice of Business Update & Investor Presentation
28 Jun 2024 03:16 PM
RNS
Conversion Notice and Total Voting Rights
18 Jun 2024 07:00 AM
RNS
AxisBiotix Acne study reports positive data
29 May 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
11 Apr 2024 11:44 AM
RNS
Holding(s) in Company
05 Apr 2024 07:00 AM
RNS
Conversion Notice & Total Voting Rights
22 Mar 2024 07:00 AM
RNS
Half-year Report
18 Mar 2024 11:36 AM
RNS
Holding(s) in Company
18 Mar 2024 07:00 AM
RNS
New research project and CSO to return to academia
12 Mar 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
08 Mar 2024 09:43 AM
RNS
Notice of Results
28 Feb 2024 12:41 PM
RNS
Conversion notice and alternative financing
27 Feb 2024 07:00 AM
RNS
Positive Interim AxisBiotix Acne study results
20 Feb 2024 07:00 AM
RNS
Dermatonics to launch Once Heel Balm in AMEA
09 Feb 2024 07:00 AM
RNS
Conversion Notice and Total Voting Rights
06 Feb 2024 07:31 AM
RNS
Dermatonics Full Year trading update
26 Jan 2024 07:00 AM
RNS
Completion of Acquisition of Dermatonics
25 Jan 2024 07:00 AM
RNS
Acquisition of Dermatonics
25 Jan 2024 07:00 AM
RNS
£5.0m Convertible Bond Facility & First Drawdown
29 Dec 2023 10:49 AM
RNS
Result of AGM
29 Dec 2023 10:49 AM
RNS
Result of AGM
29 Dec 2023 08:13 AM
RNS
Update on transaction timelines to early 2024
06 Dec 2023 07:00 AM
RNS
Notice of AGM and posting of Annual Report
30 Nov 2023 05:25 PM
RNS
Final Results
30 Nov 2023 07:00 AM
RNS
AxisBiotix-Ps™ to launch on Amazon UK
24 Nov 2023 07:00 AM
RNS
Holding(s) in Company
23 Nov 2023 03:37 PM
RNS
Holding(s) in Company
22 Nov 2023 07:00 AM
RNS
Update regarding Nominated Adviser and Broker
21 Nov 2023 07:00 AM
RNS
Result of Retail Offer
17 Nov 2023 07:00 AM
RNS
Result of Placing
16 Nov 2023 04:35 PM
RNS
Retail Offer
16 Nov 2023 04:33 PM
RNS
Placing and Retail Offer
25 Oct 2023 07:25 AM
RNS
Acne study, Trading and Auditor updates
19 Oct 2023 07:00 AM
RNS
Extension of Croda contract for SkinBiotix™
15 Sep 2023 09:00 AM
RNS
health authority approval for AxisBiotix in France
05 Sep 2023 07:00 AM
RNS
Update on acne programme
31 Jul 2023 12:51 PM
RNS
Holding(s) in Company
21 Jun 2023 07:00 AM
RNS
Regulatory Approval
14 Jun 2023 04:46 PM
RNS
Business progress update
10 May 2023 07:00 AM
RNS
SkinBiotix and AxisBiotix Update
14 Apr 2023 07:00 AM
RNS
Director/PDMR Shareholding
28 Mar 2023 01:45 PM
RNS
Replacement Half-year Report
28 Mar 2023 07:00 AM
RNS
Half-year Report
27 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
09 Mar 2023 05:18 PM
RNS
Director/PDMR Shareholding
09 Mar 2023 05:18 PM
RNS
Director/PDMR Shareholding
07 Mar 2023 07:00 AM
RNS
AxisBiotix-PsT approved for launch in Europe

SkinBioTherapeutics is a life science company that develops technologies to improve health by harnessing the human microbiome.

SkinBioTherapeutics is based in Newcastle upon Tyne, United Kingdom.

SkinBioTherapeutics is listed in London under the ticker SBTX.

SBTX share price listed at 16p in 2017.

UK 100

Latest directors dealings